Mito-priming as a method to engineer Bcl-2 addiction-Reference-Cited by-同舟云学术

Mito-priming as a method to engineer Bcl-2 addiction

Published:2016-02-02 Issue:1 Volume:7 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Lopez Jonathan^ORCID,Bessou Margaux,Riley Joel S.,Giampazolias Evangelos,Todt Franziska,Rochegüe Tony,Oberst Andrew,Green Douglas R.,Edlich Frank,Ichim Gabriel,Tait Stephen W. G.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms10538.pdf

Reference32 articles.

1. Tait, S. W. & Green, D. R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11, 621–632 (2010).

2. Tait, S. W., Ichim, G. & Green, D. R. Die another way--non-apoptotic mechanisms of cell death. J. Cell. Sci. 127, 2135–2144 (2014).

3. Czabotar, P. E., Lessene, G., Strasser, A. & Adams, J. M. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 15, 49–63 (2014).

4. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).

5. Certo, M. et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer cell 9, 351–365 (2006).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large transient assemblies of Apaf1 constitute the apoptosome in cells;2024-07-03

2. Canonical and Noncanonical Functions of the BH3 Domain Protein Bid in Apoptosis, Oncogenesis, Cancer Therapeutics, and Aging;Cancers;2024-06-12

3. Venetoclax Combined with Intensive Chemotherapy: A New Hope for Refractory and/or Relapsed Acute Myeloid Leukemia?;Journal of Clinical Medicine;2024-01-18

4. A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals major role of BAX in BH3 mimetics response;Blood Journal;2023-12-14

5. Intracellular BAPTA directly inhibits PFKFB3, thereby impeding mTORC1-driven Mcl-1 translation and killing MCL-1-addicted cancer cells;Cell Death & Disease;2023-09-08